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Antifungal compoundThe aims of this study were to investigate the antifungal activity as a bioactive property of dihydrodehydro-
diconiferyl alcohol 9′-O-β-D-glucoside (DDDC9G) and the mode of action(s) involved in its effect. Antifungal
susceptibility testing showed that DDDC9G possessed potent antifungal activities toward various fungal
strains with almost no hemolytic effect. To understand the antifungal mechanism(s) of DDDC9G, we con-
ducted the following experiments in this study using Candida albicans. Fluorescence experiments using the
probes, 1, 6-diphenyl-1, 3, 5-hexatriene (DPH) and propidium iodide suggested that DDDC9G perturbed
the fungal plasma membrane. Consecutively, the analysis of the transmembrane electrical potential (ΔΨ)
with 3, 3′-dipropylthiadicarbocyanine iodide [DiSC3(5)] and bis-(1, 3-dibutylbarbituric acid) trimethine oxo-
nol [DiBAC4(3)] indicated that DDDC9G induced membrane-depolarization. Furthermore, model membrane
studies were performed with rhodamine-labeled giant unilamellar vesicles (GUVs), calcein encapsulating
large unilamellar vesicles (LUVs), and FITC-dextran (FD) loaded LUVs. These results demonstrated that the
antifungal effects of DDDC9G upon the fungal plasma membrane were through the formation of pores with
the radii between 0.74 nm and 1.4 nm. Finally, in three dimensional (3D) ﬂow cytometric contour plots, a re-
duced cell size was observed as a result of osmolarity changes from DDDC9G-induced structural and func-
tional membrane damages. Therefore, the present study suggests that DDDC9G exerts its antifungal effect
by damaging the membrane through pore formation in the fungal plasma membrane.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Over the past few decades, the prevalence of fungal infections has
been progressively increasing, for instance, systemic infections occur-
ring in patients who received solid organ, and allogenic bone marrow
transplantation, and cancer chemotherapy [1]. The morbidity and mor-
tality resulting from these invasive fungal infections caused by oppor-
tunistic yeasts and ﬁlamentous fungi remain at unacceptably high
levels [2]. Hence, fungal infections are a challenging clinical problem
and intensive efforts have been made to develop clinically useful anti-
fungal agents. However, fungal infections are difﬁcult to treat since the
majority of antifungal drugs are also toxic to human cells, which have
similar mechanisms for DNA, RNA, and protein synthesis [3], andl alcohol 9′-O-β-D-glucoside;
n; CLSI, Clinical and Laboratory
l)-2,5-diphenyl-2H-tetrazolium
3,3′-dipropylthiacarbocyanine;
xonol; GUV, giant unilamellar
olamine; PI, phosphatidylinosi-
s; FITC, ﬂuorescein isothiocya-
er
+82 53 955 5522.
l rights reserved.resistant organisms have emerged due to the limited number of avail-
able agents used to cure these fungal infections [4].
Plants, unlike mammals that possess a circulating immune system
such as immunoglobulin molecules and phagocytes, lack a somatic
adaptive immunity [5]. Instead, they rely on innate immunity as self-
defense mechanisms including structural barriers that prevent patho-
gens from gaining entrance and spreading throughout the plant as
well as chemical compounds that inhibit the growth of pathogens.
[6]. Inhibitory compounds in plants contain various antimicrobial pep-
tides, proteins, and nonproteinaceous secondary metabolites [7].
Among them, phytochemicals as nonproteinaceous secondary metabo-
lites are non-nutritive bioactive compounds that act as protective
agents against external stress and pathogenic stress [8]. The phyto-
chemicals, including saponin, helihumulone, 3,5,7-trihydroxyﬂavone,
anolignan B, and so on, have been known to have antimicrobial effect
[9]. In addition, natural phytochemicals with bioactive properties
have less human toxicity [10] and are more cost effective [11]. These
properties have been applied in the search for new, safer, and more
efﬁcacious medicinal plants as a source of bioactive compounds to
combat serious fungal infections.
Dihydrodehydrodiconiferyl alcohol 9′-O-β-D-glucoside (DDDC9G)
is a neolignan glucoside, a secondary metabolite discovered in Trache-
lospermum asiaticum, Styrax japonica S. et Z, and so on [12,13]. Several
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DDDC9G on the matrix metalloproteinase-1 inhibitory activity [13],
human immunodeﬁciency virus (HIV)–host cell fusion inhibitory ac-
tivity [14], and estrogenic activity [15]; however no useful effects
were demonstrated. The structure of DDDC9G consists of two frag-
ments, the coniferyl alcohols as the aglycone moiety and a glucoside
as the glycoside moiety, which are linked by a rotatable β-glycosidic
bond [12]. The coniferyl alcohol, a component of DDDC9G, is associat-
ed with the defense mechanisms of trees and acts as an inhibitor of
fungal growth [16]. Some cases of fungal inhibition by various glyco-
sides and aglycones have been reported [17]. This structure shows
potential for clinical applications and also, inﬂuences the pharmaco-
kinetic properties [18].
In this study, we investigated the antifungal effect of DDDC9G and
determined its mode of action.2. Materials and methods
2.1. Extraction and isolation of DDDC9G from S. japonica
The stem bark of S. japonica was collected from Jogyesan, Sunch-
eon, Chonnam, Korea. A voucher specimen was deposited at the Her-
barium of the College of Pharmacy, Chosun University, Korea (CSU-
964-17). The air-dried stem bark of S. japonica (654 g) was cut and
extracted with methanol (MeOH) at 80 °C for 4 h. The MeOH extract
(120.32 g) was suspended in water and then partitioned sequential-
ly with equal volumes of dichloromethane (CH2Cl2), ethyl acetate
(EtOAc), and n-butanol (n-BuOH). The EtOAc fraction (4 g) was sub-
jected to column chromatography over a silica gel by eluting it with
an EtOAc:i-propanol:H2O (20:1:0.5). The groups were then divided
into 7 separate groups based on their TLC proﬁles. The subgroup,
E5 (830.0 mg) was then puriﬁed by column chromatography on a
silica gel eluting it with a CHCl3:MeOH:Me2CO:H2O (50:4:2:0.3)
and was followed by a gel ﬁltration column chromatography
(Sephadex LH-20, MeOH:H2O=1:1) to yield DDDC9G (40 mg).
The physico-chemical data including the 1H NMR, 13C NMR, and
HSQC spectra of DDDC9G were identical with those reported in
the literature [13].2.2. Fungal strains and antifungal activity assay
Candida albicans (ATCC 90028) and Candida parapsilosis (ATCC
22019) were obtained from the American Type Culture Collection
(ATCC) (Manassas, VA, USA). Trichosporon beigelii (KCTC 7707) and
Malassezia furfur (KCTC 7744) were obtained from the Korean Collec-
tion for Type Cultures (KCTC) at the Korea Research Institute of Bio-
science and Biotechnology (KRIBB) (Daejeon, Korea).
The fungal strains were cultured in YPD broth (Difco) with aera-
tion at 28 °C, and the M. furfur was cultured at 32 °C in a modiﬁed
YM broth (Difco) containing 1% olive oil. The cell suspensions were
adjusted to obtain standardized populations by measuring the turbid-
ity with a spectrophotometer (DU530; Beckman, Fullerton, CA,
U.S.A.). Fungal cells at the log phase (2×106/ml) were inoculated
into 0.1 ml/wells of YPD or YM broth, and then, dispensed to microti-
ter plates. Minimum inhibitory concentrations (MICs) were deter-
mined with a two-fold serial dilution of the test compounds, based
on the Clinical and Laboratory Standards Institute (CLSI) method
and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) assay [19]. After 48 h of incubation, the minimal concen-
tration of compounds required to prevent the growth of the
microorganisms was determined, and deﬁned as the MIC. The growth
was measured with a microtiter ELISA Reader (Molecular Devices
Emax, CA, USA) by monitoring the absorption at 580 nm. The MIC
values were determined by three independent assays [20].2.3. Hemolytic activity assay
The hemolytic activity of the compounds was evaluated by deter-
mining the release of hemoglobin from a 4% suspension of human
erythrocytes at 414 nm with an ELISA reader. Hemolytic levels of
zero and 100% were determined in a phosphate buffered saline
(PBS: 35 mM phosphate buffer/150 mM NaCl, pH 7.4) alone and
with 0.1% Triton X-100, respectively. The hemolysis percentage was
calculated with the following equation: hemolysis (%)=[(Abs414nm
in the compound solution−Abs414nm in PBS)/(Abs414nm in 0.1%
Triton X-100−Abs414nm in PBS)]×100 [21].
2.4. Membrane ﬂuorescence intensity measurements
The ﬂuorescence intensity from the plasma membrane of C. albi-
cans cells labeled with 1,6-diphenyl-1,3,5-hexatriene (DPH) (Molecu-
lar probes, Eugene, Oregon, U.S.A.) was used to monitor changes in
the membrane dynamics. Fungal cells (2×106/ml YPD) treated with
the compounds were incubated for 2 h at 28 °C. Control cells were in-
cubated without the compounds. Samples of the fungal cultures were
ﬁxed with 0.37% formaldehyde for 30 min and washed with PBS. The
pellets were frozen with liquid nitrogen. For labeling, the cells were
thawed and resuspended in PBS. The suspension was incubated
with 0.6 mM DPH (dissolved in N,N-dimethylformamide at 6 mM)
for 45 min at 28 °C and washed with PBS buffer [22]. To homogenize
the cells, the samples on ice were sonicated (VC 130, Sonics & Ma-
terials, Inc., USA), and then, separated by centrifugation. The super-
natant including DPH-labeled lipid matrix was transferred to a
cuvette and the ﬂuorescence intensity of DPH was measured by a
Spectroﬂuorophotometer (Shimadzu RF-5301PC, Shimadzu, Kyoto,
Japan) at 350 nm excitation and 425 nm emission wavelengths.
2.5. Propidium iodide inﬂux assay
C. albicans cells in the log phase (2×106/ml YPD), resuspended in
PBS, were treated with 50.0 μM of the compounds and incubated for
2 h at 28 °C. Cells were then harvested by centrifugation and sus-
pended in PBS. Subsequently, the cells were treated with 9 μM propi-
dium iodide and incubated for 5 min at room temperature [23]. The
cells were analyzed using ﬂuorescence microscopy (Microphot FXA
photomicroscope, Nikon, Japan).
2.6. Analysis of the changes in the transmembrane electrical
potential (ΔΨ)
2.6.1. Real-time kinetics: changes in the ΔΨ
C. albicans (2×106/ml) were cultured aerobically at 35 °C for 24 h
in RPMI 1640 (165 mMMOPS, pH 7.0, with L-glutamine and NaHCO3).
The cells were washed with Ca2+ and Mg2+ free PBS and changes in
the ΔΨ were measured with a membrane potential sensitive probe,
3,3′-dipropylthiacarbocyanine [diSC3(5)]. Changes in the ﬂuores-
cence due to the collapse of the ΔΨ by 50.0 μM of the compounds
were continuously monitored using a Spectroﬂuorophotometer at
an excitation wavelength of 622 nm and an emission wavelength of
670 nm. The experiment was repeated three times under each condi-
tion to ensure reproducibility [24].
2.6.2. The changes in the ΔΨ after incubation for 2 h
The log-phased cells of C. albicans (2×106/ml YPD) were har-
vested and resuspended in PBS buffer, containing 50.0 μM of the
compounds. After incubation for 2 h, the cells were harvested by
centrifugation and suspended in PBS. Subsequently, the cells were
treated with 50 μg of bis-(1,3-dibutylbarbituric acid) trimethine
oxonol [DiBAC4(3)] (Molecular Probes, Eugene, OR, USA) as the indi-
cator of membrane potential. Flow cytometric analysis was done
with a FACSCalibur ﬂow cytometer (Becton Dickinson, San Jose,
Table 1
The antifungal activity of DDDC9G and antibiotics.
Fungal strains MIC (μM)
DDDC9G Amphotericin B Fluconazole
C. albicans ATCC 90028 12.5 3.1–6.3 3.1
C. parapsilosis ATCC 22019 6.3 1.6–3.1 3.1
T. beigelii KCTC 7707 12.5 1.6–3.1 3.1
M. furfur KCTC 7744 12.5 3.1 6.3
1650 H. Choi et al. / Biochimica et Biophysica Acta 1818 (2012) 1648–1655CA, USA) [25]. The histogram is representative of at least three sep-
arate experiments.
2.7. Preparation and microscopic observation of giant unilamellar
vesicles (GUVs)
GUVs were prepared by the electroformation method, developed
by Angelova and Dimitrov [26,27]. A lipid mixture solution
(3.75 mg/ml) of phosphatidylcholine (PC)/phosphatidylethanol-
amine (PE)/rhodamine-conjugated PE/phosphatidylinositol (PI)/
ergosterol (5:3.9:0.1:1:2, w/w/w/w/w) dissolved in chloroform was
spread onto an ITO (indium tin oxide) coated glass in a spin coater
(Spin Coater, ACE-1020 Series) at 500 rpm for 5 min. The lipid-
coated ITO glass was evaporated under a vacuum for 3 h. Both lipid-
coated and uncoated glasses were separated by a distance of 2 mm
with a thin Teﬂon spacer. After ﬁlling the chamber with 10 mM
HEPES buffer solution (pH 7.4), a sinusoidal 1.7 V (peak to peak,
sine wave) and 10 Hz frequency with a sweep function generator
(Protek, SWEEP FUNCTION GENERATOR 9205C) were applied for 2 h
at room temperature. To detach the vesicles from the plate, a sinusoi-
dal 4 V (peak to peak) and 4 Hz frequency were applied for 10 min.
Aliquots of the resultant GUV solution were observed with an
inverted ﬂuorescence phase-contrast microscope (Leica, DFC420C).
Compound solutions were added after the selection of a single GUV.
2.8. Calcein leakage measurement
Large unilamellar vesicles (LUVs) encapsulating calcein, composed
of PC/ PE/PI/ergosterol (5:4:1:2, w/w/w/w), were prepared by vor-
texing the dried lipids in a dye buffer solution (70 mM calcein,
10 mM Tris, 150 mM NaCl, and 0.1 mM EDTA [pH 7.4]). The suspen-
sion was freeze-thawed in liquid nitrogen for 11 cycles and extruded
through polycarbonate ﬁlters (two stacked 200 nm pore size ﬁlters)
with a LiposoFast extruder (Avestin Inc., Ottawa, Canada). Untrapped
calcein was removed using a gel ﬁltration process on a Sephadex G-50
column. The leakage of calcein from the LUVs was monitored at 25 °C
by measuring the ﬂuorescence intensity at an excitation wavelength
of 490 nm and an emission wavelength of 520 nm, with a Spectro-
ﬂuorophotometer. To determine 100% dye release, 30 μl of 10% Triton
X-100 was added to the vesicles. The percentage of dye leakage
caused by the compounds was calculated as follows: dye leakage
(%)=100×(F−F0)/(Ft−F0), where F represents the ﬂuorescence
intensity achieved after addition of the compounds and F0 and Ft rep-
resent the ﬂuorescence intensities without the compounds and with
Triton X-100, respectively [24].
2.9. Preparation of liposomes containing dextrans and leakage assay
Dextrans labeled with ﬂuorescein isothiocyanate (FITC) (FD4,
FD10 and FD20) were used to evaluate the extent of membrane dam-
age induced by the compounds. LUVs containing FD were prepared
with the reverse-phase evaporation method [28]. To prepare lipo-
somes containing FD, buffer I (1 ml, 50 mM potassium phosphate,
pH 7.4, with 0.1 mM EDTA) containing 2 mg/ml of FD, was sonicated
(JAC 2010, KODO, Korea) for 30 min with 20 mg/ml of lipid [PC/PE/PI/
ergosterol (5:4:1:2, w/w/w/w)] solution in chloroform on ice. Chloro-
form was removed with a rotary vacuum evaporator for 2 h at 25 °C,
resulting ﬁrst in the formation of a viscous gel and then, a liposome
suspension. Buffer I (2 ml) was added and the suspension was evap-
orated further for the removal of eventual traces of chloroform. The
liposome suspension was sonicated, centrifuged and washed for sev-
eral cycles at 13,000 rpm for 30 min to remove the unentrapped-FD.
For the assay, a suspension of liposomes containing FD (compound/
liposome=0.1) was treated with the compounds. The mixture
(1 ml, ﬁnal volume) was stirred for 10 min in the dark and then cen-
trifuged at 13,000 rpm for 20 min. The supernatant was recoveredand its ﬂuorescence intensity recorded at an excitation wavelength
of 494 nm and an emission wavelength of 520 nm with a Spectro-
ﬂuorophotometer. The maximum ﬂuorescence intensity was deter-
mined by adding 30 μl of 10% Triton X-100 to a liposome
suspension. The percentage of FD leakage was calculated the same
as the percentage of calcein leakage.
2.10. Three dimensional ﬂow cytometric contour plot analysis
C. albicans cells in log phase (2×106/ml YPD), resuspended in PBS,
were treated with 50.0 μM of the compounds and incubated for 2 h at
28 °C. After incubation, the cells were harvested by centrifugation and
suspended in PBS. The morphological changes were analyzed by
FACSCalibur ﬂow cytometer. Non-stained living cells were evaluated
for each sample by excitation with 488 nm light from an argon ion
laser by determining their position on a forward scatter (FS) versus
side scatter (SS) contour plot [29].
3. Results
3.1. Antifungal and hemolytic effects of DDDC9G
In this study, amphotericin B and ﬂuconazole, which are consid-
ered the medicine for the treatment of systemic fungal infections,
were used as positive controls for the comparison of the antifungal
effect of DDDC9G. Amphotericin B is believed to form pores, by
complexing the sterol in the cell membrane, and that this direct ac-
tion induces cell death [30]. Fluconazole has been suggested to block
biosynthesis of ergosterol in the fungal membrane by interacting
with 14-α-demethylase, and this indirect action results in the inhi-
bition of fungal growth and replication [31]. As shown in Table 1,
the fungal strains tested were susceptible to DDDC9G with MIC
values in the range of 6.25–12.5 μM, while amphotericin B and ﬂu-
conazole had MIC values in the range of 1.56–6.25 μM.
Furthermore, we evaluated the hemolytic effect of DDDC9G by
measuring the contents of the hemoglobin released from human
erythrocytes. The result showed that DDDC9G revealed no hemolytic
activity except at the highest concentration of 100 μM while ampho-
tericin B induced much more potent hemolytic activities at all tested
concentration levels. Fluconazole did not induce hemolytic effects at
the tested concentrations (Table 2). Therefore, we did the remaining
experiments using concentrations of DDDC9G less than 100 μM due
to its cytotoxicity level.
3.2. DDDC9G-induced changes in the integrity of the plasma membrane
The effect of DDDC9G on fungal cells was monitored with DPH and
propidium iodide. DPH, as a membrane probe interacting with an acyl
group of the lipid bilayer, was employed to investigate the changes in
membrane dynamics. The level of the ﬂuorescence from the DPH-
labeled membranes of C. albicans was analyzed in the absence or
presence of the compounds. The results showed that DDDC9G de-
creased the DPH ﬂuorescence intensity of the plasma membrane
compared to the non-treated cells, and that the fungal plasma
Table 2
Human erythrocyte lysis assay against DDDC9G and antibiotics.
Compounds Hemolysis (%)
100.0 μM 50.0 μM 25.0 μM 12.5 μM 6.3 μM 3.1 μM
DDDC9G 13.9 0 0 0 0 0
Amphotericin B 100 100 74.4 32.7 10.6 3.7
Fluconazole 0 0 0 0 0 0
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of ﬂuorescence intensity was observed in the presence of amphoteri-
cin B, however, the smallest change in the DPH ﬂuorescence intensity
was monitored in the C. albicans cells exposed to ﬂuconazole due to
its indirect action (Fig. 1A).
Propidium iodide exhibiting a red ﬂuorescence is a membrane-
impermeant dye. We monitored the inﬂux of propidium iodide by
ﬂuorescence microscopy. The result showed that ﬂuorescence of the
propidium iodide was not present in the cells exposed to ﬂuconazole
(Fig. 1Bb). However, nucleic acids in C. albicans cells treated with
DDDC9G and amphotericin B ﬂuoresced red (Fig. 1Bc and Bd) and
both compounds induced an increases in the ﬂuorescence of propi-
dium iodide in a dose-dependent manner (Fig. 1Be), demonstrating
that the fungal membrane was injured by the compounds.3.3. DDDC9G-induced membrane depolarization
To further examine whether DDDC9G can affect the functions of
the fungal plasma membrane, the membrane-depolarization experi-
ments were conducted using the potential-sensitive dye, diSC3(5)
and DiBAC4(3). As shown in Fig. 2A, after diSC3(5) (at 60 s) was
added to a C. albicans cell suspension, a stable baseline of ﬂuorescence
intensity was achieved. The subsequent treatment of DDDC9G (at
180 s) resulted in a rapid increase in ﬂuorescence intensity, demon-
strating that the ΔΨ was dissipated by the compound treatment. In
addition to monitoring the real-time changes induced by DDDC9G,
the amounts of accumulated DiBAC4(3) in C. albicans cells incubated
for 2 h were analyzed with ﬂow cytometry. Cells treated with
DDDC9G and amphotericin B caused a greater accumulation of
DiBAC4(3) than that of untreated cells (Fig. 2Ba) and the ﬂuorescence
intensity depended on compounds concentrations (Fig. 2Bb). The re-
sults meant that the compounds induced membrane depolarizationFig. 1. C. albicans cells (2×106/ml) were incubated with compounds for 2 h at 28 °C. The
intensity were expressed as relative ﬂuorescence unit (RFU) after treatment with the com
independent experiments are shown. (B) C. albicans cells treated with compounds were v
pidium iodide inﬂux. The bar corresponds to 10 μm. (a) Cells were not treated, (b) 50.0 μM
of cells stained with propidium iodide by treatment of compounds at various concentratio
shown.in C. albicans. However, ﬂuconazole at the same concentration had
no effect on the ΔΨ (Fig. 2A and B).
3.4. DDDC9G-induced pore formation in the fungal plasma membrane
To visualize the membrane-disruptive action of DDDC9G, we ob-
served themorphological changes of the GUVs in response to the com-
pounds. GUV with yeast cell size mimics the outer leaﬂets of the
plasma membrane of C. albicans composed of PC/PE/PI/ergosterol
(5:4:1:2, w/w/w/w) [32]. A small fraction (0.8%, w/w) of the lipids
used for the formation of GUV is ﬂuorescently labeled. The label is rho-
damine bound to the head of a derivative of PE. We selected a single
GUV in aliquots of the solution and then treated the compounds. The
shape of the single vesicle was monitored continuously with ﬂuores-
cence phase-contrast microscopy. Due to the photobleaching of rho-
damine, as a control, we monitored the changes in the ﬂuorescence
intensity in the absence of the compound. The ﬂuorescent intensity
was unchanged (Fig. 3D); therefore, we excluded any signiﬁcant
photobleaching of the ﬂuorescent probes demonstrating the decrease
in ﬂuorescence intensity provoked by the action of compounds inter-
acting with the GUVs. Similar to photobleaching, after the addition of
ﬂuconazole, the ﬂuorescence level of the GUV remained consistent
over 30 s (Fig. 3C). In the case of DDDC9G and amphotericin B, the ob-
served responses of each GUV to the compoundswere different.When
treated with amphotericin B, the diameter of the GUV rapidly dimin-
ished with a concomitant reduction in the ﬂuorescence intensity of
the GUV membrane over time (Fig. 3B). However, when treated with
DDDC9G, the rhodamine level also gradually weakened but the diam-
eter and circular shape of the GUV maintained intact without visible
breaks by lytic action (Fig. 3A).
3.5. Determination of the pore size induced by DDDC9G
To investigate the extent of the membrane damage induced by the
compounds, the leakage of calcein (average molecular weight=623 Da,
Stokes–Einstein radius=0.74 nm) [33], FD4 (average molecular
weight=4 kDa, Stokes–Einstein radius=1.4 nm), FD10 (average mole-
cular weight=10 kDa, Stokes–Einstein radius=2.3 nm), and FD20
(average molecular weight=20 kDa, Stokes–Einstein radius=3.3 nm)
[34] from artiﬁcial liposomes was assessed. The model membrane study
was done using many LUVs comprised of PC/PE/PI/ergosterol (5:4:1:2,
w/w/w/w) [32]. The results showed the amount of calcein leakagechanges in the membrane integrity were detected. (A) Changes in DPH ﬂuorescence
pounds at various concentrations (12.5, 25.0, and 50.0 μM). The mean values of three
isualized under a ﬂuorescence microscope. Membrane perturbation is shown by pro-
of ﬂuconazole, (c) 50.0 μM of DDDC9G, (d) 50.0 μM of amphotericin B, and (e) percent
ns (12.5, 25.0, and 50.0 μM). The mean values of three independent experiments are
Fig. 2. Depolarization of membrane potential was detected by diSC3(5) and DiBAC4(3). (A) Real-time assay on the effect of the compounds on the ΔΨ of C. albicans cells. DiSC3(5)
was added at t=60 s (a). After internalization of the probe, at t=180 s (b), 50.0 μMof the compounds was added to monitor changes in ﬂuorescence (Ex. 622 nm and Em. 670 nm).
(B) (a) C. albicans cells (2×106/ml) were incubated with 50.0 μM of compounds for 2 h at 28 °C. Histograms showed the ﬂuorescent intensity of stained DiBAC4(3) in C. albicans
after incubation with the compounds. (b) Percent of DiBAC4(3)-positive cells by treatment of compounds at various concentrations (12.5 and 50.0 μM). The mean values of
three independent experiments are shown.
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amphotericin B caused 37.4% and 61.7% leakage of calcein from the LUVs,
respectively,whereas released calceinwas not detected in the presence of
ﬂuconazole (Fig. 4). The compounds including amphotericin B, DDDC9G,
and ﬂuconazole did not induce the release of FDs from liposomes at all
(data not shown.). These results indicated that DDDC9G andFig. 3. The response of the GUV [PC:PE:rhodamine-conjugated PE:PI:ergosterol=
5:3.9:0.1:1:2 (w/w/w/w/w)] in the presence of the compounds at 0, 10, 20, and 30 s.
(A) DDDC9G, (B) amphotericin B, (C) ﬂuconazole, and (D) photobleaching. The bar
represents 10 μm.amphotericin B made pores with radii between 0.74 nm and 1.4 nm in
the fungal model membranes.
3.6. Morphological changes induced by DDDC9G in C. albicans
The effects of DDDC9G on morphology of C. albicans were exam-
ined with ﬂow cytometric analysis where FS (x-axis) is an indicator
of size and SS (90° scattering, SS log, y-axis) is an indicator of granu-
larity. The result showed that homogeneous populations of unda-
maged cells dominated in the absence of any compounds while
DDDC9G and amphotericin B shifted the fungal population to an
area with a low FS value, which imply cell shrinkage, but did not in-
ﬂuence SS value. However, morphological changes were not detected
in cells treated with ﬂuconazole (Fig. 5).
4. Discussion
Therapy of antifungal agents currently approved for clinical use is
limited by toxicities and by resistance; Side effects due to a lack of
cell selectivity include nephrotoxicity, hepatotoxicity, and hemolytic
anemia as well as life threatening arrhythmias [35]. Mechanisms of
resistance described include the expression of efﬂux pumps to reduce
drug accumulation, alteration of target proteins, and modiﬁcation of
membrane sterol composition [36]. Thus many phytochemicals that
have relatively low human toxicity and have served as plant defenseFig. 4. Percent of calcein leakage from LUVs [PC:PE:PI:ergosterol=5:4:1:2 (w/w/w/w)]
was measured after the compound were applied for 10 min at various concentra-
tions (12.5, 25.0, and 50.0 μM). The mean values of three independent experiments
are shown.
Fig. 5. C. albicans cells (2×106/ml) were incubated with 50.0 μM of compounds for 2 h at 28 °C. Three-dimensional ﬂow cytometric contour-plot analysis of C. albicans cells treated
with compounds. FS (y-axis) is an indicator of size and SS (90° scattering, SS LOG, x-axis) is an indicator of granularity. The z-axis represents the cellular population intensity.
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bivores are appropriate and efﬁcient as antimicrobial drugs for pa-
tients. Among the plant compounds, the antimicrobial activity and
mode of action(s) of neolignans such as 8.O.4′-neolignans and
eupomatenoid-5, have been described [37,38]. The objective of this
study was to evaluate the potential of DDDC9G as an antifungal
agent against fungal strains and to explain its mode of action(s) of
its antifungal effect.
The antifungal activity of DDDC9G was ﬁrst examined. This result
showed that DDDC9G possessed signiﬁcant inhibitory effect similar to
the response to positive controls. Furthermore, we conducted a cyto-
toxicity test on human erythrocytes to assess the suitability for sys-
temic application. These results suggested that DDDC9G had
remarkable potential to be considered a novel antibiotic agent for
treating fungal diseases in humans, with selective toxicity toward
fungal cells over human erythrocytes. C. albicans, one of the various
strains that tested the susceptibility to DDDC9G, is the most preva-
lent fungal pathogen and is associated with a range of symptoms
from irritating superﬁcial infections in the oral and vaginal mucosa
to life threatening systemic diseases in immunocompromised pa-
tients [39]. Considering its medical importance, C. albicans was se-
lected as a model organism for the experiments of this study.
To understand whether DDDC9G exerts antifungal effect by tar-
geting the cell membrane as an important structural component of
the cell surface or other organelles of the cell interior after the com-
pound penetrates the cell membrane without perturbation, we inves-
tigated its effect on the membrane integrity using the probes 1, 6-
diphenyl-1, 3, 5-hexatriene (DPH) and propidium iodide. DPH, a
very hydrophobic ﬂuorescent molecule, is incorporated into thehydrophobic core of phospholipids within the cytoplasmic mem-
brane, without disturbing the structure of the lipid bilayer [40]. If
DDDC9G affects the membrane dynamics, the DPH could not interact
with an acyl group of the lipid bilayer within the plasma membrane.
The result showed the reduction of the DPH intensity and suggested
that the fungal plasma membrane was structurally perturbed when
exposed to DDDC9G. Propidium iodide, used in the following exper-
iment, only enters membrane compromised cells and then, interca-
lates between the bases with the guanine and the cytosine pair or
with a stoichiometry of one dye per 4–5 base pairs. After binding
to nucleic acids, red ﬂuorescence of propidium iodide increases 20
fold [41,42]. From the ﬂuorescence experiment, we observed the dif-
fusion of the propidium iodide into the cells through the damaged
plasma membrane, and therefore, could ascertain the membrane-
active mechanisms of DDDC9G. Maintaining the integrity of the cyto-
plasmic membrane is crucial to many essential functions of microbial
pathogens, including gradient formation and selective permeability,
cellular energetic, biopolymers synthesis, and other key virulence de-
terminants [43]. In this respect, an alteration in the physical state of
the plasma membrane induced by DDDC9G may interfere with one
or more functions directly or indirectly.
Successively, the collapse of ΔΨ, which may be one of the dam-
ages by membrane perturbation, was detected ﬂuorimetrically with
diSC3(5) and DiBAC4(3). DiSC3(5) as a potential-sensitive probe is
translocated into the lipid bilayer according to the magnitude of the
electrical potential gradient of the membrane. Thereafter, it becomes
concentrated in the membranes and self-quenches the ﬂuorescence
of the dye. Observing the result of the release of the probe into the
medium accompanied by an increase in ﬂuorescent intensity, we
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is an anionic lipophilic dye sensitive to the membrane potential and
enters only depolarized cells according to the Nernst equation,
where it binds reversibly to lipid-rich intracellular components
[45]. Normal cells were scarcely stained with DiBAC4(3), which indi-
cated that these cells have a negative internal charge due to the re-
tention of ΔΨ. In cells incubated with DDDC9G for 2 h, like the
preceding real-time assay, DiBAC4(3) could penetrate and bind to
the hydrophobic core of the lipid membrane and resulted in an in-
crease in the ﬂuorescence quantum yield and emission. The ob-
served cellular depolarization was not a transient event and the
depolarization induced by DDDC9G was sustained. Furthermore,
these results could conﬁrm that DDDC9G exerts its antifungal activ-
ity by means of membrane-active mechanisms, which was sug-
gested by the analysis of DPH ﬂuorescence intensity and the assay
regarding the PI inﬂux.
To understand the way DDDC9G contribute to the membrane de-
stabilization, we examined the response of a single GUV to treatment
with the compounds. GUVs with an average diameter greater than
10 μm provide information on changes in structural and physical
properties during interaction with antimicrobial agents, such as elas-
tic properties of phospholipid membranes, shape change of vesicles,
interaction of cytoskeleton proteins with the membranes, membrane
fusion, and reconstitution of artiﬁcial cells. Therefore, it is believed
that GUVs are helpful model systems in biomembrane studies
[33,46]. As mentioned above, both the decrease in the rhodamine
level and the maintenance of the spherical shape of a GUV demon-
strate that DDDC9G exerted its activity by a pore-forming, not a
lytic action. This study clearly indicated that the main target of
DDDC9G was the lipid regions of the fungal plasma membrane and
pore formation, a direct effect, increased the membrane permeabil-
ity. In addition to the real-time tracking of single GUV, many LUVs
were extensively used to measure the leakage extent of the internal
contents, such as small ﬂuorescent probes, induced by interaction
with various kinds of substances including drugs, peptides, and pro-
teins [47]. Calcein and FD leakage assays serve as methods of deter-
mining the average pore sizes and leakage contents of dyes using
various molecular weights. Contrary to the calcein leakage assay,
DDDC9G did not cause the release of FDs from any liposomes. It
means that the radii of the pores induced by DDDC9G between
0.74 nm and 1.4 nm were enough to change the membrane charac-
teristics [48].
Finally, the morphological changes from the DDDC9G-induced
structural and functional membrane damages of C. albicans were in-
vestigated by FACScan analysis plotting the FS and SS. In the pres-
ence of DDDC9G, the cell population appeared in the 3D density
plots with a smaller size (decreased FS) compared to the non-
treated cell population, which supports the ﬁnding of the propidium
iodide inﬂux with ﬂuorescence microscopy and indicates the mem-
brane damage [49]. In conclusion, from these results it can be con-
strued that DDDC9G formed pores resulting in an increased
permeability of the fungal membrane and causing the free transport
of ions, inducing a cytoplasmic ionic imbalance. Hence, the fungal
cells experienced osmolarity changes in their environment and this
osmotic instability led to cell shrinkage. These actions induce a cancel-
ling of the molecular charges and a slowing or stopping of essential
functions, such as membrane-coupled respiration, and eventually the
death of fungal cells [50].
In this study, we investigated the antifungal activities of DDDC9G
and its mode of action(s) in C. albicans. DDDC9G showed remarkable
antifungal activities on various fungal strains with almost no hemo-
lytic effect and exerted an antifungal effect by damaging the plasma
membrane through a pore-forming action. Therefore, it can be sug-
gested that DDDC9G has potential for clinical application as an anti-
fungal agent and that this compound can be used to synthesize
more potent antifungal agents.Acknowledgements
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